8-105419192-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_012082.4(ZFPM2):āc.89A>Gā(p.Glu30Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00419 in 1,613,668 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0030 ( 2 hom., cov: 32)
Exomes š: 0.0043 ( 16 hom. )
Consequence
ZFPM2
NM_012082.4 missense
NM_012082.4 missense
Scores
1
7
11
Clinical Significance
Conservation
PhyloP100: 7.00
Genes affected
ZFPM2 (HGNC:16700): (zinc finger protein, FOG family member 2) The zinc finger protein encoded by this gene is a widely expressed member of the FOG family of transcription factors. The family members modulate the activity of GATA family proteins, which are important regulators of hematopoiesis and cardiogenesis in mammals. It has been demonstrated that the protein can both activate and down-regulate expression of GATA-target genes, suggesting different modulation in different promoter contexts. A related mRNA suggests an alternatively spliced product but this information is not yet fully supported by the sequence. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.037163347).
BP6
Variant 8-105419192-A-G is Benign according to our data. Variant chr8-105419192-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 6128.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-105419192-A-G is described in Lovd as [Likely_pathogenic]. Variant chr8-105419192-A-G is described in Lovd as [Likely_benign]. Variant chr8-105419192-A-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00297 (452/152316) while in subpopulation NFE AF= 0.00529 (360/68008). AF 95% confidence interval is 0.00484. There are 2 homozygotes in gnomad4. There are 206 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 452 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZFPM2 | NM_012082.4 | c.89A>G | p.Glu30Gly | missense_variant | 2/8 | ENST00000407775.7 | NP_036214.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZFPM2 | ENST00000407775.7 | c.89A>G | p.Glu30Gly | missense_variant | 2/8 | 1 | NM_012082.4 | ENSP00000384179.2 |
Frequencies
GnomAD3 genomes AF: 0.00297 AC: 452AN: 152198Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
452
AN:
152198
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00269 AC: 669AN: 248808Hom.: 4 AF XY: 0.00274 AC XY: 370AN XY: 134990
GnomAD3 exomes
AF:
AC:
669
AN:
248808
Hom.:
AF XY:
AC XY:
370
AN XY:
134990
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00432 AC: 6315AN: 1461352Hom.: 16 Cov.: 31 AF XY: 0.00425 AC XY: 3088AN XY: 726950
GnomAD4 exome
AF:
AC:
6315
AN:
1461352
Hom.:
Cov.:
31
AF XY:
AC XY:
3088
AN XY:
726950
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00297 AC: 452AN: 152316Hom.: 2 Cov.: 32 AF XY: 0.00277 AC XY: 206AN XY: 74472
GnomAD4 genome
AF:
AC:
452
AN:
152316
Hom.:
Cov.:
32
AF XY:
AC XY:
206
AN XY:
74472
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
11
ALSPAC
AF:
AC:
14
ESP6500AA
AF:
AC:
6
ESP6500EA
AF:
AC:
48
ExAC
AF:
AC:
326
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Pathogenic:3Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | ZFPM2: BP4, BS1, BS2 - |
Diaphragmatic hernia 3 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2015 | - - |
Double outlet right ventricle Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2015 | - - |
Tetralogy of Fallot Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2015 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 08, 2017 | - - |
46,XY sex reversal 9 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | - - |
46,XY sex reversal 3 Benign:1
Benign, no assertion criteria provided | research | Reproductive Development, Murdoch Childrens Research Institute | Aug 26, 2019 | - - |
ZFPM2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 16, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
T
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at